The global cardiopulmonary bypass equipment market was valued at USD 356.00 Million in 2024, driven by increasing incidence of cardiopulmonary conditions across the globe. The market is expected to grow at a CAGR of 4.24% during the forecast period of 2025-2034, with the values likely to reach USD 539.25 Million by 2034 .
Growth in Strategic Partnerships and Mergers to Meet Rising Cardiopulmonary Bypass Equipment Market Demand
In April 2024, NuvoAir Medical partnered with Privia Medical Group to provide virtual-first care model and transform cardiopulmonary care. The partnership focused on leveraging NuvoAir's advanced digital health technologies to enhance the management of cardiopulmonary diseases, making healthcare more accessible and efficient. By integrating these technologies, the partnership aims to offer continuous, high-quality care outside conventional healthcare settings. The patients can benefit from real-time monitoring of their respiratory health, personalized treatment adjustments, and direct communication with healthcare providers, from wherever they are.
In July 2023, Inspira ™ Technologies entered into a collaboration agreement with Perfusion Solution, Inc. This collaboration involved combining Inspira™ Technologies' innovative oxygenation technology, INSPIRA™ ART100 product with Perfusion Solution's expertise in perfusion systems. Such collaborations are aimed at developing and refining solutions in order to improve patient outcomes during critical care and surgical procedures, propelling the market value in the forecast period.
Autotransfusion systems are also gaining popularity, owing to its ability to reduce the need for blood transfusions as it allows the reinfusion of patients own blood during the procedure. This also minimizes the risk of blood-borne infections. Therefore, its adoption is rising attributed to its enhanced patient outcomes in surgical procedures where blood loss is significant.
On the other hand, double roller pump provides control and precision making it essential for time taking and complex surgeries. This segment is projected to grow as the demand for precision soars.
Asia Pacific region is likely to witness the fastest growth rate, accredited to increasing improvements in the healthcare infrastructure and significant budget allocation by government to promote quality research and development in the medical domain. Awareness around cardiopulmonary health is also one of the factors expected to boost the market value of the region in the forecast period.
This product will be delivered within 3-5 business days.
Global Cardiopulmonary Bypass Equipment Market Overview
Cardiopulmonary bypass is an equipment that temporarily takes over the function of the heart and lungs during a cardiac surgery by maintaining the circulation of blood and oxygen throughout the body. The equipment typically includes oxygenators, pumps, filters, and tubing. The market growth is also driven by an increasing preference for minimally invasive procedures, and technological advancements among others.Global Cardiopulmonary Bypass Equipment Market Growth Drivers
Increasing Prevalence of Cardiopulmonary Diseases to Affect the Market Landscape Significantly
With rising incidence of cardiopulmonary conditions, the market has been witnessing an influx of new and innovative products to provide enhanced patient outcomes. According to World Health Organization (WHO), approximately 17.9 million people died from cardiovascular diseases in 2019, which represents 32% of all global deaths. With the rise in aging population, WHO estimates that between 2015 and 2050, the proportion of the world's population aged above 60 years will nearly double from 12% to 22%. Since geriatric population is more susceptible to develop chronic conditions, the market value for cardiopulmonary bypass equipment is likely to grow.Growth in Strategic Partnerships and Mergers to Meet Rising Cardiopulmonary Bypass Equipment Market Demand
In April 2024, NuvoAir Medical partnered with Privia Medical Group to provide virtual-first care model and transform cardiopulmonary care. The partnership focused on leveraging NuvoAir's advanced digital health technologies to enhance the management of cardiopulmonary diseases, making healthcare more accessible and efficient. By integrating these technologies, the partnership aims to offer continuous, high-quality care outside conventional healthcare settings. The patients can benefit from real-time monitoring of their respiratory health, personalized treatment adjustments, and direct communication with healthcare providers, from wherever they are.
In July 2023, Inspira ™ Technologies entered into a collaboration agreement with Perfusion Solution, Inc. This collaboration involved combining Inspira™ Technologies' innovative oxygenation technology, INSPIRA™ ART100 product with Perfusion Solution's expertise in perfusion systems. Such collaborations are aimed at developing and refining solutions in order to improve patient outcomes during critical care and surgical procedures, propelling the market value in the forecast period.
Global Cardiopulmonary Bypass Equipment Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:Increasing Prevalence of Cardiopulmonary Diseases
The increase in burden for cardiopulmonary diseases worldwide is a primary driver for cardiopulmonary bypass equipment. With the increase in older adults, age related issues comprising heart conditions also increases. With lifestyle changes lacking physical activity, high stress levels and poor diet leads to conditions like hypertension, diabetes, and obesity. This leads to a significant decline in heart and gut health and can lead to coronary artery disease, arrythmia or heart attack.Technological Advancements
There is a shift towards integrating real-time monitoring systems and automation in cardiopulmonary bypass equipment. Such innovations provide safety and precision in procedures which offers better control to the surgeons during operations. Furthermore, the innovation in constructing smaller and more compact bypass machines is broadening the scope for minimally invasive surgeries.Shift Toward Outpatient Cardiac Surgeries
The adoption of minimally invasive surgical procedures has resulted in performing more surgeries in out-patient settings, thereby reducing prolonged hospitalization. Being economically advantageous, such settings are likely to boost the demand for cardiopulmonary bypass equipment.Regulatory and Reimbursement Shifts
The shift in insurance reimbursement policies and regulatory framework across different countries are impacting the market. Stringent regulations are enforced for efficacy and safety of medical devices including cardiopulmonary bypass machines. As a result, healthcare systems are prioritizing cost-effectiveness leading to reimbursement for cardiac procedures.Global Cardiopulmonary Bypass Equipment Market Segmentation
Cardiopulmonary Bypass Equipment Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:Market Breakup by Product
- Heart-Lung Machines
- Oxygenators
- Autotransfusion Systems
- Others
Market Breakup by Application
- Cardiovascular
- Respiratory
- Hemodialysis
- Others
Market Breakup by Type
- Single Roller Pump
- Double Roller Pump
Market Breakup by End User
- Hospitals
- Specialty Clinics
- Dialysis Centers
- Ambulatory Surgery Centers
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Cardiopulmonary Bypass Equipment Market Share
Heart-Lung Machines are Expected to Lead the Market Share Based on Product
Based on product, the market segmentation includes heart-lung machines, oxygenators, autotransfusion systems, and others. In cardiac surgeries these products are necessary to conduct cardiopulmonary bypass. Heart-lung machines are integral for bypass procedures and is expected to lead the market. This product allows surgeons to perform time consuming and complex surgeries by maintaining blood circulation without interrupting any organ function.Autotransfusion systems are also gaining popularity, owing to its ability to reduce the need for blood transfusions as it allows the reinfusion of patients own blood during the procedure. This also minimizes the risk of blood-borne infections. Therefore, its adoption is rising attributed to its enhanced patient outcomes in surgical procedures where blood loss is significant.
By Type, Single Roller Pumps are Expected to Hold a Significant Market Value
Based on type, the market constitutes single roller pump and double roller pump. Single roller pumps are known for their simplicity and cost-effectiveness, majorly utilized in surgeries demanding shorter bypass durations. There are known for their reliability and affordability. This pump is accessible to a wide range of healthcare facilities from hospitals to clinics. Continuous advancements in functionality and design of single roller pump are aimed to reduce blood trauma and increase patient outcome.On the other hand, double roller pump provides control and precision making it essential for time taking and complex surgeries. This segment is projected to grow as the demand for precision soars.
Global Cardiopulmonary Bypass Equipment Market Analysis by Region
The regional segment offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North American market is expected to expand at a significant rate. This region is supported by access to advance healthcare and developed healthcare infrastructure.Asia Pacific region is likely to witness the fastest growth rate, accredited to increasing improvements in the healthcare infrastructure and significant budget allocation by government to promote quality research and development in the medical domain. Awareness around cardiopulmonary health is also one of the factors expected to boost the market value of the region in the forecast period.
Leading Players in the Global Cardiopulmonary Bypass Equipment Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Medtronic PLC
- LivaNova PLC
- MAQUET Holding B.V. & Co. KG.
- Terumo Corporation
- Braile Biomedica Ltd
- Tianjin Medical
- Senko Medical Instrument Manufacturing Co. Ltd.
- Abbott
- Becton, Dickinson and Company
- Beijing ZKSK Technology Co., Ltd.
- Nipro Corporation
- MicroPort Scientific Corporation
- Precision Medical, Inc.
- Zimmer Biomet Holdings, Inc.
- Technowood Corporation
Key Questions Answered in the Global Cardiopulmonary Bypass Equipment Market Report
- What was the global cardiopulmonary bypass equipment market value in 2024?
- What is the global cardiopulmonary bypass equipment market forecast outlook for 2025-2034?
- What are the regional markets covered in the report?
- What is market segmentation based on product?
- What is the market breakup based on type?
- Who are the major end users in the market?
- Where does cardiopulmonary bypass equipment find its application?
- What are the major factors aiding the global cardiopulmonary bypass equipment market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How does the prevalence and incidence of cardiopulmonary diseases affect the market landscape?
- What are the major global cardiopulmonary bypass equipment market trends?
- How does the rise in the geriatric population impact the market size?
- What product will dominate the market share?
- Which application area is expected to have a high market value in the coming years?
- Which type segment will experience the highest demand in the market segment?
- Who are the key players involved in the cardiopulmonary bypass equipment market?
- What is patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Global Cardiopulmonary Bypass Equipment Market Overview
4 Global Cardiopulmonary Bypass Equipment Market Landscape*
5 Global Cardiopulmonary Bypass Equipment Market Dynamics
6 Global Cardiopulmonary Bypass Equipment Market Segmentation (2018-2034)
7 North America Cardiopulmonary Bypass Equipment Market (2018-2034)
8 Europe Cardiopulmonary Bypass Equipment Market (2018-2034)
9 Asia Pacific Cardiopulmonary Bypass Equipment Market (2018-2034)
10 Latin America Cardiopulmonary Bypass Equipment Market (2018-2034)
11 Middle East and Africa Cardiopulmonary Bypass Equipment Market (2018-2034)
12 Regulatory Framework
13 Patent Analysis
14 Grants Analysis
15 Funding and Investment Analysis
16 Partnership and Collaborations Analysis
17 Supplier Landscape
18 Global Cardiopulmonary Bypass Equipment Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Medtronic PLC
- LivaNova PLC
- MAQUET Holding B.V. & Co. KG.
- Terumo Corporation
- Braile Biomedica Ltd
- Tianjin Medical
- Senko Medical Instrument Manufacturing Co. Ltd.
- Abbott
- Becton, Dickinson and Company
- Beijing ZKSK Technology Co., Ltd.
- Nipro Corporation
- MicroPort Scientific Corporation
- Precision Medical, Inc.
- Zimmer Biomet Holdings, Inc.
- Technowood Corporation